Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis

Trial Profile

Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Sodium cromoglicate (Primary)
  • Indications Pruritus
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Patara Pharma
  • Most Recent Events

    • 05 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 20 Aug 2016 This trial has been completed in Poland according to European Clinical Trials Database record.
    • 03 May 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top